Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Risk-directed Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01470976
What this trial is testing

Goal-directed Resuscitation in High-risk Patients Undergoing Cardiac Surgery

Who this might be right for
Perioperative Hemodynamic OptimizationCardiac Surgery
University of Sao Paulo 126
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07291557
What this trial is testing

PSMA-PET Directed Radiation Therapy for High-Risk Prostate Cancer

Who this might be right for
Prostate Cancer
AHS Cancer Control Alberta 250
Not applicableWithdrawnNCT03213574
What this trial is testing

Impact of GDT in Robot-assisted Laparoscopic Urological Surgery for Low to Moderate Risk Patients

Who this might be right for
Vascular HypotensionHypovolemiaHypervolemia
Loma Linda University
Not applicableStudy completedNCT02936089
What this trial is testing

Risk Stratification-directed Therapy for AML With t(8;21) /AML1-ETO+

Who this might be right for
Acute Myeloid LeukemiaRisk Stratification
Nanfang Hospital, Southern Medical University 207
Post-approval studies (Phase 4)Study completedNCT03420261
What this trial is testing

Hemostasis Evolution During Fluid Loading in Abdominal Surgery. Effects of Fluid Choice: Saline Versus Hydroxyethyl Starch (HAEMO Study)

Who this might be right for
Postoperative MorbidityPostoperative MortalityHemostasis Change
University Hospital, Clermont-Ferrand 56
Testing effectiveness (Phase 2)Study completedNCT03621696
What this trial is testing

Surgery Followed by Risk-Directed Post-Operative Adjuvant Therapy for HPV-Related Oropharynx Squamous Cell Carcinoma: "The Minimalist Trial (MINT)"

Who this might be right for
HPV Related Oropharyngeal Squamous Cell Carcinoma
Washington University School of Medicine 63
Testing effectiveness (Phase 2)Active Not RecruitingNCT05767359
What this trial is testing

CAR- PRISM (PRecision Intervention Smoldering Myeloma)

Who this might be right for
Multiple MyelomaSmoldering Multiple Myeloma
Dana-Farber Cancer Institute 20
Testing effectiveness (Phase 2)Study completedNCT00729612
What this trial is testing

Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Greg Otterson 63
Not applicableLooking for participantsNCT04266574
What this trial is testing

BRAIN-targeted Goal-directed Therapy in High-risk Patients undeRgOing Major electIve SurgEry: the BRAIN-PROMISE Study

Who this might be right for
SurgeryPerioperative Complication
Istituto Clinico Humanitas 200
Not applicableStudy completedNCT04792242
What this trial is testing

Effect of PCO2 Gap Algorithm Application on Outcome of High Risk Surgical Patients Undergoing Major Abdominal Surgeries

Who this might be right for
Major Abdominal Surgeries
South Valley University 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07569965
What this trial is testing

Frontline Risk-Adapted Optimization of Novel Targeted Immunotherapy Evaluation in High-Risk MCL

Who this might be right for
Mantle Cell Lymphoma (MCL)
Miltenyi Biomedicine GmbH 52
Testing effectiveness (Phase 2)Looking for participantsNCT04724928
What this trial is testing

Evaluating the Impact of 18F-FDG-PET-CT on Risk Stratification and Treatment Adaptation for Patients with Muscle Invasive Bladder Cancer

Who this might be right for
Muscle-Invasive Bladder Carcinoma
University Hospital, Ghent 156
Not applicableUnknownNCT01456702
What this trial is testing

Risk Stratification and Goal-directed Volume Therapy

Who this might be right for
Fluid Volume Disorder
Charite University, Berlin, Germany 300
Not applicableLooking for participantsNCT07003646
What this trial is testing

Reperfusion Treatment in Acute Pulmonary Embolism

Who this might be right for
Pulmonary Embolism
Sahlgrenska University Hospital 220
Testing effectiveness (Phase 2)Looking for participantsNCT05535166
What this trial is testing

Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma

Who this might be right for
Medulloblastoma
St. Jude Children's Research Hospital 130
Not applicableEnded earlyNCT01570465
What this trial is testing

Prospective Study on Severe Infections on Acute Myeloid Leukemia (AML) Patients

Who this might be right for
AMLAdult
Gruppo Italiano Malattie EMatologiche dell'Adulto 144
Not applicableUnknownNCT03620955
What this trial is testing

Risk-stratified Therapy Based on Molecular Cytogenetic Aberration and Treatment Response in AML

Who this might be right for
Risk-directed TherapyCytogenetic AbnormalityMolecular Abnormality+1 more
Nanfang Hospital, Southern Medical University 1,000
Not applicableLooking for participantsNCT06220435
What this trial is testing

Tumor-directed Radiation Therapy for Patients With the Highest Risk Category of Localized Prostate Cancer

Who this might be right for
Prostate Cancer
Region Skane 76
Not applicableLooking for participantsNCT06156943
What this trial is testing

Advanced Goal-Directed Impedancemetry Strategy for Lung Resection Surgery

Who this might be right for
High-risk Lung Resection Surgery
Hospices Civils de Lyon 722
Not applicableUnknownNCT01985269
What this trial is testing

Modified Directly Observed Antiretroviral Therapy

Who this might be right for
HIV
Moi University 511
Next Page